Brief: Acura Pharmaceuticals, Mlv & Co terminate market issuance sales agreement

Acura Pharmaceuticals

30/06/2015 21:44

June 30 (Reuters) - Acura Pharmaceuticals Inc  ACUR.O : 
 * Says on June 30, co and mlv & co. llc mutually terminated at market issuance 
   sales agreement entered into on April 18, 2013 
 * Through termination date, co sold 2.2 million shares of common stock for 
   gross proceeds of $3.5 million pursuant to mlv agreement 
 
 * Source text for Eikon  ID:nEOLb2scgs  
 
 * Further company coverage  ACUR.O   
 
 ((Bengaluru Newsroom; +1 646 223 8780))